关注
Thomas L Vaughan
Thomas L Vaughan
Professor, University of Washington, Fred Hutchinson Cancer Research Center
在 u.washington.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
EM El-Omar, CS Rabkin, MD Gammon, TL Vaughan, HA Risch, ...
Gastroenterology 124 (5), 1193-1201, 2003
11852003
Population attributable risks of esophageal and gastric cancers
LS Engel, WH Chow, TL Vaughan, MD Gammon, HA Risch, JL Stanford, ...
Journal of the National Cancer Institute 95 (18), 1404-1413, 2003
9212003
Bone sarcomas linked to radiotherapy and chemotherapy in children
MA Tucker, GJ D'Angio, JD Boice Jr, LC Strong, FP Li, M Stovall, BJ Stone, ...
New England Journal of Medicine 317 (10), 588-593, 1987
8971987
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
WH Chow, WJ Blot, TL Vaughan, HA Risch, MD Gammon, JL Stanford, ...
JNCI: Journal of the National Cancer Institute 90 (2), 150-155, 1998
7881998
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
MD Gammon, H Ahsan, JB Schoenberg, AB West, H Rotterdam, S Niwa, ...
Journal of the National Cancer Institute 89 (17), 1277-1284, 1997
7761997
An Inverse Relation between cagA+ Strains of Helicobacter pylori Infection and Risk of Esophageal and Gastric Cardia Adenocarcinoma
WH Chow, MJ Blaser, WJ Blot, MD Gammon, TL Vaughan, HA Risch, ...
Cancer research 58 (4), 588-590, 1998
7181998
Epidemiology and pathogenesis of esophageal cancer
RS Holmes, TL Vaughan
Seminars in radiation oncology 17 (1), 2-9, 2007
7172007
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
TL Vaughan, S Davis, A Kristal, DB Thomas
Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1995
6901995
Nutrient intake and risk of subtypes of esophageal and gastric cancer
ST Mayne, HA Risch, R Dubrow, WH Chow, MD Gammon, TL Vaughan, ...
Cancer Epidemiology Biomarkers & Prevention 10 (10), 1055-1062, 2001
6252001
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
DC Farrow, TL Vaughan, PD Hansten, JL Stanford, HA Risch, ...
Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1998
5841998
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
BJ Reid, X Li, PC Galipeau, TL Vaughan
Nature reviews Cancer 10 (2), 87-101, 2010
4612010
Occupational exposure assessment in case–control studies: opportunities for improvement
K Teschke, AF Olshan, JL Daniels, AJ De Roos, CG Parks, M Schulz, ...
Occupational and environmental medicine 59 (9), 575-594, 2002
4542002
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium
MB Cook, F Kamangar, DC Whiteman, ND Freedman, MD Gammon, ...
Journal of the National Cancer Institute 102 (17), 1344-1353, 2010
3792010
Central adiposity and risk of Barrett’s esophagus
ZR Edelstein, DC Farrow, MP Bronner, SN Rosen, TL Vaughan
Gastroenterology 133 (2), 403-411, 2007
3782007
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
C Hoyo, MB Cook, F Kamangar, ND Freedman, DC Whiteman, ...
International journal of epidemiology 41 (6), 1706-1718, 2012
3672012
Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease
MF Buas, TL Vaughan
Seminars in radiation oncology 23 (1), 3-9, 2013
3502013
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus
RE Rudolph, TL Vaughan, BE Storer, RC Haggitt, PS Rabinovitch, ...
Annals of Internal Medicine 132 (8), 612-620, 2000
3432000
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors
GL Hold, CS Rabkin, WH Chow, MG Smith, MD Gammon, HA Risch, ...
Gastroenterology 132 (3), 905-912, 2007
3292007
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
DC Farrow, TL Vaughan, C Sweeney, MD Gammon, WH Chow, HA Risch, ...
Cancer Causes & Control 11, 231-238, 2000
3162000
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma
PC Galipeau, X Li, PL Blount, CC Maley, CA Sanchez, RD Odze, K Ayub, ...
PLoS medicine 4 (2), e67, 2007
2892007
系统目前无法执行此操作,请稍后再试。
文章 1–20